University of Minnesota-Clinical Research Unit

Minneapolis, Minnesota 55455

1 studies enrolling now · 4 studies all time

What they study most

Advanced Solid Tumor, Cytomegalovirus Infection, Pompe Disease (Late-onset), Thrombotic Thrombocytopenic Purpura (TTP)

Studies at this site

• A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors — Recruiting now
• A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP) — Completed
• A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age — Stopped early
• A Study Comparing ATB200/AT2221 With Alglucosidase Alfa/Placebo in Adult Subjects With Late-onset Pompe Disease — Completed